To compare clinical outcomes after randomization to hysterectomy versus medical treatment in patients with chronic abnormal uterine bleeding refractory to medroxyprogesterone acetate.
Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of California, San Francisco, California, USA. learman1@obgyn.ucsf.edu
